Your session is about to expire
← Back to Search
Standard of Care plus Study Treatment for Soft Tissue Injury (CWI Trial)
Phase 3
Waitlist Available
Led By Alexander Stojadinovic, MD
Research Sponsored by Walter Reed Army Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days following initial treatment
Awards & highlights
CWI Trial Summary
The purpose of this study is to determine if adding shock wave therapy to standard-of-care wound treatment for traumatic extremity wounds helps them heal faster.
CWI Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 90 days following initial treatment
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days following initial treatment
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Time to complete wound healing. For purposes of this study, the definition of "healed" is wound closure with total epithelialization of the soft tissue defect, confirmed at two consecutive study visits.
Secondary outcome measures
Assessment of relative burden of disease (trauma) between treatment groups by comparing mean values of the eight standard scales of the Medical Outcome Study 36-Item Short Form Health Survey (SF-36).
Durability of wound closure (i.e., status of wound at one month following determination of "healed").
For patients who have not achieved healed status at Day 90, the percent of wounds at Day 90 with lesser healing (≤50% epithelialization) versus with greater healing (>50% but < 100% epithelialization) as determined by planimetric CDM.
+8 moreCWI Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Standard of Care plus Study TreatmentExperimental Treatment1 Intervention
Standard of Care Treatment plus study treatment
Group II: Standard of CareActive Control1 Intervention
Standard of Care Treatment; no study treatment
Find a Location
Who is running the clinical trial?
Walter Reed Army Medical CenterLead Sponsor
69 Previous Clinical Trials
20,726 Total Patients Enrolled
Tissue Regeneration TechnologiesIndustry Sponsor
1 Previous Clinical Trials
200 Total Patients Enrolled
Alexander Stojadinovic, MDPrincipal InvestigatorWalter Reed Army Medical Center
2 Previous Clinical Trials
540 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger